-
1.
REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders.
Poptsi, E, Tsardoulias, E, Moraitou, D, Symeonidis, AL, Tsolaki, M
Journal of Alzheimer's disease : JAD. 2019;(3):783-801
Abstract
BACKGROUND Subjective cognitive decline (SCD) and mild cognitive impairment (MCI) are acknowledged stages of the clinical spectrum of Alzheimer's disease (AD), and cognitive control seems to be among the first neuropsychological predictors of cognitive decline. Existing tests are usually affected by educational level, linguistic abilities, cultural differences, and social status, constituting them error-prone when differentiating between the aforementioned stages. Creating robust neuropsychological tests is therefore prominent. OBJECTIVE The design of a novel psychometric battery for the cognitive control and attention assessment, free of demographic effects, capable to discriminate cognitively healthy aging, SCD, MCI, and mild Dementia (mD). METHODS The battery initial hypothesis was tuned using iterations of administration on random sampling healthy older adults and people with SCD, MCI, and mD, from the area of Thessaloniki, Greece. This resulted in the first release of the REflexes MEasurement DEviceS for Alzheimer battery (REMEDES for Alzheimer-R4Alz). RESULTS The first release lasts for almost an hour. The battery was design to assess working memory (WM) including WM storage, processing, and updating, enriched by episodic buffer recruitment. It was also designed to assess attention control abilities comprising selective, sustained, and divided attention subtasks. Finally, it comprises an inhibitory control, a task/rule switching or set-shifting, and a cognitive flexibility subtask as a combination of inhibition and task/rule switching abilities. CONCLUSION The R4Alz battery is an easy to use psychometric battery with increasing difficulty levels and assumingly ecological validity, being entertaining for older adults, potentially free of demographic effects, and promising as a more accurate and early diagnosis tool of neurodegeneration.
-
2.
Caffeine affects children's ERPs and performance in an equiprobable go/no-go task: Testing a processing schema.
Barry, RJ, De Blasio, FM, Fogarty, JS
Psychophysiology. 2019;(5):e13330
Abstract
Caffeine's stimulant properties were used to test a proposed processing schema for children's processing stages in the equiprobable auditory go/no-go task. Active control-related ERP components were hypothesized to be differentially enhanced by caffeine. Caffeine (80 mg) was administered in a counterbalanced, randomized, double-blind, placebo-controlled, cross-over study of 24 children, aged 8-12 years. Four blocks of an equiprobable auditory go/no-go task were completed on each of two occasions, while on or off caffeine. ERP data sets from each condition (caffeine/go, placebo/go, caffeine/no-go, placebo/no-go) were subjected to separate temporal PCAs with extraction and varimax rotation of all components. Caffeine significantly reduced reaction time and go omission errors, and enhanced go PN, N2c, and P3b, and no-go N1-1 and N2b. This selective enhancement of different go/no-go components by caffeine matched the predicted amplification of biomarkers of children's active control processing in this task. Some unexpected findings also support further refinements in the child processing schema.
-
3.
Effects of Hand Exercise on Eating Action in Patients With Alzheimer's Disease.
Chen, LL, Li, H, Chen, XH, Jin, S, Chen, QH, Chen, MR, Li, N
American journal of Alzheimer's disease and other dementias. 2019;(1):57-62
-
-
Free full text
-
Abstract
We aim to investigate whether a popular hand exercise could be used to improve the action of eating in patients with Alzheimer's disease (AD). A 6-month intervention was conducted in 60 patients with AD who live in a nursing home. They were divided into hand exercise and control groups. Patients of the control group maintained their daily routine. The improvement of Edinburgh Feeding Evaluation in Dementia scale in hand exercise group was significantly greater than in the control group ( P = .003). Significant differences in time of autonomous eating and time of simulated eating between patients in the hand exercise and control groups ( P < .05) were noted. The improvements in accuracy of eating action and coordination of eating action from baseline were significant in hand exercise group compared to the control group ( P = .020 and .014, respectively). Hand exercise is a safe and effective intervention to improve the feeding and eating of people with AD.
-
4.
The Effect of Citicoline Supplementation on Motor Speed and Attention in Adolescent Males.
McGlade, E, Agoston, AM, DiMuzio, J, Kizaki, M, Nakazaki, E, Kamiya, T, Yurgelun-Todd, D
Journal of attention disorders. 2019;(2):121-134
Abstract
OBJECTIVE This study assessed the effects of citicoline, a nutraceutical, on attention, psychomotor function, and impulsivity in healthy adolescent males. METHOD Seventy-five healthy adolescent males were randomly assigned to either the citicoline group ( n = 51 with 250 or 500 mg citicoline) or placebo ( n = 24). Participants completed the Ruff 2&7 Selective Attention Test, Finger Tap Test, and the Computerized Performance Test, Second Edition (CPT-II) at baseline and after 28 days of supplementation. RESULTS Individuals receiving citicoline exhibited improved attention ( p = 0.02) and increased psychomotor speed ( p = 0.03) compared with those receiving placebo. Higher weight-adjusted dose significantly predicted increased accuracy on an attention task ( p = 0.01), improved signal detectability on a computerized attention task ( p = 0.03), and decreased impulsivity ( p = 0.01). DISCUSSION Adolescent males receiving 28 days of Cognizin® citicoline showed improved attention and psychomotor speed and reduced impulsivity compared to adolescent males who received placebo.
-
5.
Effect of caffeine ingestion on competitive rifle shooting performance.
Nygaard, H, Riksaasen, S, Hjelmevoll, LM, Wold, E
PloS one. 2019;(10):e0224596
Abstract
PURPOSE The purpose of the present study was to test if caffeine ingestion affects rifle shooting accuracy in trained shooters. METHODS Twenty trained shooters performed 4 shooting tests in a randomized, double-blinded, placebo controlled crossover design; 2 identical tests after placebo ingestion and 2 after ingestion of 300 mg caffeine. The tests consisted of 30 shots in prone position and 30 in standing position on a 10 ring electronic target, on a distance of 50 metres, without any time limit, at rest. RESULTS Caffeine supplementation entailed a mean decrease in shooting performance by 11.8 points (95% CI: 6.7 to 17.0, effect size: 0.9). This was primarily a result of an 11.3 (95% CI: 7.2 to 15.4, effect size: 0.9) point decrease during shooting in standing position and not in prone position (0.6 point decrease, 95% CI: -2.1 to 3.2, effect size: 0.1). CONCLUSIONS We conclude that prior ingestion of 300 mg caffeine impairs rifle shooting accuracy in trained shooters when performed in standing but not in prone position.
-
6.
An Exploratory Double-Blind Study of Caffeine Effects on Performance and Perceived Exertion in Judo.
Saldanha da Silva Athayde, M, Kons, RL, Detanico, D
Perceptual and motor skills. 2019;(3):515-529
Abstract
This study analyzed the effects of caffeine ingestion during judo matches on judo athletes' match-derived performance and perceived exertion responses. We applied a double-blind randomized crossover (caffeine vs. placebo conditions) research design. Twelve male athletes performed three 5-minute matches separated by 15 minutes of passive rest. Immediately after each match, the athletes completed ratings of perceived exertion (RPEs), and one minute before beginning the second and third matches, they provided ratings of perceived recovery (RPRs). We filmed all matches for subsequent analysis of the athletes' technical skills. We found no interaction between condition and time of RPE, RPR, and match-derived technical variables, but number of attacks and RPR decreased over the matches, and RPE increased in both conditions. Three participants showed individual positive responses to caffeine ingestion for number of attacks. Attacks, efficiency, and effectiveness presented low sensitivity in both conditions, as only large changes could be identified. We conclude that caffeine ingestion did not provoke changes in either perceived exertion or match-derived performance. Match-derived technical variables were not sensitive for detecting small or medium effects of caffeine, but perceived exertion may detect at least medium effect after caffeine ingestion.
-
7.
Effects of 90 Days of Resveratrol Supplementation on Cognitive Function in Elders: A Pilot Study.
Anton, SD, Ebner, N, Dzierzewski, JM, Zlatar, ZZ, Gurka, MJ, Dotson, VM, Kirton, J, Mankowski, RT, Marsiske, M, Manini, TM
Journal of alternative and complementary medicine (New York, N.Y.). 2018;(7):725-732
-
-
Free full text
-
Abstract
OBJECTIVE The purpose of this trial was to study the effects of chronic resveratrol use on cognitive function in humans. DESIGN The authors conducted a double-blind, Phase IIa randomized, placebo-controlled trial to obtain preliminary estimates of the effects of resveratrol supplementation on cognitive function over a 90-day period in older adults. LOCATION University of Florida in Gainesville, FL. SUBJECTS Sedentary, overweight older adults (N = 32; age range: 65-93 years, M age = 73.34 years, SD age = 7.02 years). INTERVENTION Participants were randomized to one of three treatment groups (placebo, 300 mg/day resveratrol, 1000 mg/day resveratrol) for 90 days. OUTCOME MEASURES Cognitive function was assessed before and after treatment using a well-characterized test battery: Trail Making, Digits Forward and Backward, Erikson-Flanker, Controlled Oral Word Association, Hopkins Verbal Learning Test-Revised, and Task Switching. RESULTS Psychomotor speed improved on the Trail Making Test part A in participants taking 1000 mg/day of resveratrol compared with participants in both the 300 mg/day condition and the placebo condition (p = 0.02). CONCLUSION This pilot study suggests that 90 days of resveratrol supplementation at a dose of 1000/mg per day selectively improves psychomotor speed but does not significantly affect other domains of cognitive function in older adults. These findings provide modest support to further study the effects of resveratrol on cognitive function in older adults.
-
8.
Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity.
Mürner-Lavanchy, IM, Doyle, LW, Schmidt, B, Roberts, RS, Asztalos, EV, Costantini, L, Davis, PG, Dewey, D, D'Ilario, J, Grunau, RE, et al
Pediatrics. 2018;(5)
Abstract
BACKGROUND AND OBJECTIVES Caffeine is effective in the treatment of apnea of prematurity. Although caffeine therapy has a benefit on gross motor skills in school-aged children, effects on neurobehavioral outcomes are not fully understood. We aimed to investigate effects of neonatal caffeine therapy in very low birth weight (500-1250 g) infants on neurobehavioral outcomes in 11-year-old participants of the Caffeine for Apnea of Prematurity trial. METHODS Thirteen academic hospitals in Canada, Australia, Great Britain, and Sweden participated in this part of the 11-year follow-up of the double-blind, randomized, placebo-controlled trial. Measures of general intelligence, attention, executive function, visuomotor integration and perception, and behavior were obtained in up to 870 children. The effects of caffeine therapy were assessed by using regression models. RESULTS Neurobehavioral outcomes were generally similar for both the caffeine and placebo group. The caffeine group performed better than the placebo group in fine motor coordination (mean difference [MD] = 2.9; 95% confidence interval [CI]: 0.7 to 5.1; P = .01), visuomotor integration (MD = 1.8; 95% CI: 0.0 to 3.7; P < .05), visual perception (MD = 2.0; 95% CI: 0.3 to 3.8; P = .02), and visuospatial organization (MD = 1.2; 95% CI: 0.4 to 2.0; P = .003). CONCLUSIONS Neonatal caffeine therapy for apnea of prematurity improved visuomotor, visuoperceptual, and visuospatial abilities at age 11 years. General intelligence, attention, and behavior were not adversely affected by caffeine, which highlights the long-term safety of caffeine therapy for apnea of prematurity in very low birth weight neonates.
-
9.
Impact of a purported nootropic supplementation on measures of mood, stress, and marksmanship performance in U.S. active duty soldiers.
Barringer, N, Crombie, A, Kotwal, R
Journal of the International Society of Sports Nutrition. 2018;(1):26
Abstract
BACKGROUND The purpose of this study was to determine the impact of a commercially available purported nootropic supplement on mood, stress, and rifle marksmanship accuracy and engagement time via an Engagement Skills Trainer. METHODS In this double-blind, placebo-controlled trial, 43 U.S. active duty Soldiers participating in a professional military course were assigned to treatment (n = 20; 16 males and 4 females) or placebo (n = 23; 15 males and 8 females) based on initial marksmanship score. The study period was 31 days (testing performed on days 1 and 31, supplementation days 2 through 30). Participants were instructed to consume 2 pills at breakfast and 1 pill at dinner for a total of 3 pills per day (1925 mg) of either the Alpha Brain® nootropic supplement or a placebo. Height, weight, cortisol (in a hair sample), body composition using multi-frequency tetrapolar bioelectrical impedance (InBody 720), and marksmanship (Engagement Skills Trainer 2000). Marksmanship was assessed in the prone position with zeroed M-4 rifles with a twenty target protocol with targets presenting and remaining for 3 s at set intervals. Participants' performance were assessed with hits versus misses, distance of hit from target center mass (DCM), and target engagement speed. Statistical analysis via SPSS Statistics 21 (IBM) was conducted using a repeated measures ANOVA with significance set at P < 0.5. RESULTS There was no statistically significant difference between Treatment and Placebo for hits (TreatmentPre 18.5 ± 1.5, TreatmentPost 19.4 ± 0.8, PlaceboPre18.2 ± 2.9, PlaceboPost19.4 ± 1.3), initial reaction time in seconds (TreatmentPre 1.65 ± 0.28, TreatmentPost 1.43 ± 0.28, PlaceboPre1.59 ± 0.29, PlaceboPost1.41 ± 0.21), mean reaction time in seconds (TreatmentPre 1.60 ± 0.20, TreatmentPost 1.41 ± 0.16, PlaceboPre1.61 ± 0.51, PlaceboPost1.46 ± 0.56), or distance from center mass in centimeters (TreatmentPre 11.28 ± 4.28, TreatmentPost 11.92 ± 4.23, PlaceboPre10.52 ± 5.29, PlaceboPost10.94 ± 4.64). A significant time effect (P < 0.5) was found for both groups on all variables except distance from center mass. Reaction time values were adjusted to give percent decrease for initial reaction and mean reaction for the Treatment group (- 12.3% ± 16, - 15.2% ± 21.6) compared to the Placebo group (- 8.3% ± 21.8, - 12.5% ± 23.5), but no significant difference was found. CONCLUSION The Alpha Brain® nootropic supplement did not have any statistically significant effects on marksmanship performance in this study. Given the rising popularity of nootropic supplements, future research on their potential impact on cognitively demanding soldier tasks, such as target discrimination scenarios, are recommended.
-
10.
Effect of alternating postures on cognitive performance for healthy people performing sedentary work.
Schwartz, B, Kapellusch, JM, Schrempf, A, Probst, K, Haller, M, Baca, A
Ergonomics. 2018;(6):778-795
Abstract
Prolonged sitting is a risk factor for several diseases and the prevalence of worksite-based interventions such as sit-to-stand workstations is increasing. Although their impact on sedentary behaviour has been regularly investigated, the effect of working in alternating body postures on cognitive performance is unclear. To address this uncertainty, 45 students participated in a two-arm, randomised controlled cross-over trial under laboratory conditions. Subjects executed validated cognitive tests (working speed, reaction time, concentration performance) either in sitting or alternating working postures on two separate days (ClinicalTrials.gov Identifier: NCT02863731). MANOVA results showed no significant difference in cognitive performance between trials executed in alternating, standing or sitting postures. Perceived workload did not differ between sitting and alternating days. Repeated measures ANOVA revealed significant learning effects regarding concentration performance and working speed for both days. These results suggest that working posture did not affect cognitive performance in the short term. Practitioner Summary: Prior reports indicated health-related benefits based on alternated (sit/stand) body postures. Nevertheless, their effect on cognitive performance is unknown. This randomised controlled trial showed that working in alternating body postures did not influence reaction time, concentration performance, working speed or workload perception in the short term.